• 1
    Matas AJ, Smith JM, Skeans MA, et al. OPTN/SRTR 2011 annual data report: Kidney. Am J Transplant 2013; 13 (Suppl. 1): 1146.
  • 2
    Fehrman-Ekholm I, Elinder CG, Stenbeck M, Tyden G, Groth CG. Kidney donors live longer. Transplantation 1997; 64: 976978.
  • 3
    Ibrahim HN, Foley R, Tan L, et al. Long-term consequences of kidney donation. N Engl J Med 2009; 360: 459469.
  • 4
    Segev DL, Muzaale AD, Caffo BS, et al. Perioperative mortality and long-term survival following live kidney donation. JAMA 303: 959966.
  • 5
    Lentine KL, Schnitzler MA, Xiao H, et al. Racial variation in medical outcomes among living kidney donors. N Engl J Med 363: 724732.
  • 6
    Delmonico FL, Dew MA. Living donor kidney transplantation in a global environment. Kidney Int 2007; 71: 608614.
  • 7
    Davis CL, Cooper M. The state of U.S. living kidney donors. Clin J Am Soc Nephrol 5: 18731880.
  • 8
    Poggio ED, Rule AD, Tanchanco R, et al. Demographic and clinical characteristics associated with glomerular filtration rates in living kidney donors. Kidney Int 2009; 75: 19791987.
  • 9
    Rule AD, Semret MH, Amer H, et al. Association of kidney function and metabolic risk factors with density of glomeruli on renal biopsy samples from living donors. Mayo Clin Proc 2011; 86: 282290.
  • 10
    Lloyd-Jones DM, Liu K, Colangelo LA, et al. Consistently stable or decreased body mass index in young adulthood and longitudinal changes in metabolic syndrome components: The coronary artery risk development in young adults study. Circulation 2007; 115: 10041011.
  • 11
    Meigs JB, Wilson PW, Fox CS, et al. Body mass index, metabolic syndrome and risk of type 2 diabetes or cardiovascular disease. J Clin Endocrinol Metab 2006; 91: 29062912.
  • 12
    Beddhu S, Kimmel PL, Ramkumar N, Cheung AK. Associations of metabolic syndrome with inflammation in CKD: Results from the Third National Health and Nutrition Examination Survey (NHANES III). Am J Kidney Dis 2005; 46: 577586.
  • 13
    Thomas G, Sehgal AR, Kashyap SR, Srinivas TR, Kirwan JP, Navaneethan SD. Metabolic syndrome and kidney disease: A systematic review and meta-analysis. Clin J Am Soc Nephrol 2011; 6: 23642373.
  • 14
    Poggio ED, Wang X, Greene T, Van Lente F, Hall PM. Performance of the modification of diet in renal disease and Cockcroft-Gault equations in the estimation of GFR in health and in chronic kidney disease. J Am Soc Nephrol 2005; 16: 459466.
  • 15
    Poggio ED, Hila S, Stephany B, et al. Donor kidney volume and outcomes following live donor kidney transplantation. Am J Transplant 2006; 6: 616624.
  • 16
    Grundy SM, Cleeman JI, Daniels SR, et al. Diagnosis and management of the metabolic syndrome: An American Heart Association/National Heart, Lung, and Blood Institute scientific statement. Circulation 2005; 112: 27352752.
  • 17
    Rule AD, Amer H, Cornell LD, et al. The association between age and nephrosclerosis on renal biopsy among healthy adults. Ann Intern Med 2010; 152: 561567.
  • 18
    Levey AS, Stevens LA, Schmid CH, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med 2009; 150: 604612.
  • 19
    Textor SC, Taler SJ, Driscoll N, et al. Blood pressure and renal function after kidney donation from hypertensive living donors. Transplantation 2004; 78: 276282.
  • 20
    Dengel DR, Goldberg AP, Mayuga RS, Kairis GM, Weir MR. Insulin resistance, elevated glomerular filtration fraction, and renal injury. Hypertension 1996; 28: 127132.
  • 21
    Wahba IM, Mak RH. Obesity and obesity-initiated metabolic syndrome: Mechanistic links to chronic kidney disease. Clin J Am Soc Nephrol 2007; 2: 550562.
  • 22
    Alexander MP, Patel TV, Farag YM, Florez A, Rennke HG, Singh AK. Kidney pathological changes in metabolic syndrome: A cross-sectional study. Am J Kidney Dis 2009; 53: 751759.
  • 23
    Glassock RJ, Rule AD. The implications of anatomical and functional changes of the aging kidney: With an emphasis on the glomeruli. Kidney Int 82: 270277.
  • 24
    Cuevas-Ramos D, Almeda-Valdes P, Arvizu M, et al. Association of the metabolic syndrome and long-term renal function in kidney donors. Transplant Proc 43: 16011606.
  • 25
    Willett WC, Dietz WH, Colditz GA. Guidelines for healthy weight. N Engl J Med 1999; 341: 427434.
  • 26
    Knowler WC, Barrett-Connor E, Fowler SE, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002; 346: 393403.
  • 27
    Sjostrom L, Lindroos AK, Peltonen M, et al. Lifestyle, diabetes and cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med 2004; 351: 26832693.
  • 28
    Horvath K, Jeitler K, Siering U, et al. Long-term effects of weight-reducing interventions in hypertensive patients: Systematic review and meta-analysis. Arch Intern Med 2008; 168: 571580.
  • 29
    Flegal KM, Kit BK, Orpana H, Graubard BI. Association of all-cause mortality with overweight and obesity using standard body mass index categories: A systematic review and meta-analysis. JAMA 2013; 309: 7182.
  • 30
    Einhorn D, Reaven GM, Cobin RH, et al. American College of Endocrinology position statement on the insulin resistance syndrome. Endocr Pract 2003; 9: 237252.
  • 31
    Waterman AD, Dew MA, Davis CL, et al. Living-donor follow-up attitudes and practices in U.S. kidney and liver donor programs. Transplantation 2013; 95: 883888.